CCND1 and endometrial cancer: These results demonstrate that SHetA2 induces G1 cell cycle arrest in association with reducing levels of the cyclin D1 G1-to-S promoter in two out of three cell lines, while altering levels of the p21 and p27 G1-to-S progression inhibitors to varying extents in different endometrial cancer cell lines.